Appendix A, Table 2. COVID-19 Treatment Guidelines Panel Financial Disclosure for Companies Related to COVID-19 Treatment or Diagnostics
Last Updated: February 29, 2024
Reporting Period: January 1, 2023, to December 31, 2023
| Panel Member | Financial Disclosure | |
|---|---|---|
| Company | Relationship | |
| Judith Aberg, MD | Emergent | Research support |
| Gilead | Research support | |
| GSK/ViiV Healthcare | Advisory board, research support | |
| Janssen | Research support | |
| Kintor | DSMB chair/member | |
| Merck | Advisory board, research support | |
| Pfizer | Research support | |
| Regeneron | Research support, protocol reviewer | |
| Adaora Adimora, MD, MPH | Gilead | Consultant, honoraria |
| Merck | Advisory board, consultant, honoraria, research support | |
| Jason Baker, MD, MS | None | N/A |
| Lisa Baumann Kreuziger, MD, MS | 3M | Spouse is an employee, stockholder |
| CSL Behring | Research support | |
| Takeda | Research support | |
| Versiti | Employee | |
| Roger Bedimo, MD, MS | Gilead | Advisory board |
| GSK/ViiV Healthcare | Advisory board | |
| Janssen | Advisory board | |
| Merck | Advisory board, research support | |
| Shionogi | Advisory board | |
| Theratechnologies | Advisory board | |
| Pamela S. Belperio, PharmD | None | N/A |
| Anoopindar Bhalla, MD | None | N/A |
| Timothy Burgess, MD | AstraZeneca | Research support |
| Danielle M. Campbell, MPH | Gilead | Advisory board |
| GSK/ViiV Healthcare | Attendee at a community stakeholder meeting, honoraria | |
| Stephen V. Cantrill, MD | None | N/A |
| Kara Chew, MD, MS | Pardes Biosciences | Consultant |
| Kathleen Chiotos, MD, MSCE | None | N/A |
| Craig Coopersmith, MD | None | N/A |
| Eric Daar, MD | Gilead | Consultant, research support |
| GSK/ViiV Healthcare | Consultant, research support | |
| Merck | Consultant | |
| Theratechnologies | Consultant | |
| Richard T. Davey, Jr., MD | None | N/A |
| Amy L. Dzierba, PharmD | None | N/A |
| Derek Eisnor, MD | None | N/A |
| Gregory Eschenauer, PharmD | None | N/A |
| Laura Evans, MD, MSc | None | N/A |
| Joseph Francis, MD, MPH | None | N/A |
| John J. Gallagher, DNP, RN | None | N/A |
| Rajesh Gandhi, MD | None | N/A |
| David V. Glidden, PhD | Gilead | Consultant |
| Neil Goldenberg, MD, PhD | Anthos Therapeutics | Advisory board, research support |
| Bayer | Advisory board, research support | |
| Boehringer Ingelheim | Research support | |
| CPC Clinical Research | DSMB chair/member | |
| Daiichi Sankyo | Steering committee chair, research support | |
| Janssen | Advisory board, research support | |
| Novartis | DSMB chair/member | |
| Birgit Grund, PhD | None | N/A |
| Roy M. Gulick, MD, MPH | None | N/A |
| Alison Han, MD | None | N/A |
| Erica J. Hardy, MD, MMSc | None | N/A |
| Carly Harrison | Novartis | Advisory board |
| Lauren Henderson, MD, MMSc | Bristol Myers Squibb | Research support |
| Sobi | Consultant, research support, travel support | |
| SkyGenic | Consultant, spouse is an employee | |
| Elizabeth S. Higgs, MD, DTM&H, MIA | None | N/A |
| Carl Hinkson, MSRC | None | N/A |
| Brenna L. Hughes, MD, MSc | None | N/A |
| Steven Johnson, MD | None | N/A |
| Marla J. Keller, MD | None | N/A |
| Arthur Kim, MD | None | N/A |
| Richard Knight, MBA | None | N/A |
| Safia Kuriakose, PharmD | None | N/A |
| H. Clifford Lane, MD | None | N/A |
| Jeffrey L. Lennox, MD | Pfizer | Spouse is an employee of Pfizer contract |
| Andrea M. Lerner, MD, MS | None | N/A |
| Mitchell M. Levy, MD | None | N/A |
| Jonathan Li, MD, MMSc | Merck | Research support |
| Christine MacBrayne, PharmD, MSCS | None | N/A |
| Gregory Martin, MD, MSc | Eagle Pharmaceuticals | Research grants review panel |
| Grifols | Research grants review panel | |
| Henry Masur, MD | None | N/A |
| Nandita R. Nadig, MD | None | N/A |
| Martha C. Nason, PhD | Bristol Myers Squibb | Stockholder |
| Medtronic | Stockholder | |
| Pragna Patel, MD, MPH, DTM&H | None | N/A |
| Alice K. Pau, PharmD | None | N/A |
| Andrew T. Pavia, MD | AstraZeneca | Consultant |
| Haleon | Honoraria | |
| Michael Proschan, PhD | None | N/A |
| Renee Ridzon, MD | None | N/A |
| Grant Schulert, MD, PhD | Boehringer Ingelheim | Consultant |
| Nitin Seam, MD | None | N/A |
| Virginia Sheikh, MD, MHS | None | N/A |
| Steven Q. Simpson, MD | None | N/A |
| Kanal Singh, MD, MPH | None | N/A |
| Susan Swindells, MBBS | GSK/ViiV Healthcare | Research support |
| Pablo Tebas, MD | Shionogi | Consultant |
| Phyllis Tien, MD, MSc | Merck | Research support |
| Timothy M. Uyeki, MD, MPH | None | N/A |
| Alpana A. Waghmare, MD | AlloVir | Research support |
| Ansun BioPharma | Research support | |
| GSK | Research support | |
| Pfizer | Research support | |
| Vir Biotechnology | Consultant, research support | |
| Cameron R. Wolfe, MBBS | AbbVie | Consultant |
| AstraZeneca | Research support | |
| Atea Pharmaceuticals | DSMB chair/member | |
| Biogen | DSMB chair/member | |
| Gilead | Advisory board | |
| Janssen | DSMB chair/member | |
| Jinoos Yazdany, MD, MPH | AstraZeneca | Consultant, research support |
| Aurinia | Research support | |
| Bristol Myers Squibb | Research support | |
| Gilead | Research support | |
| Pfizer | Consultant | |
| Key: DSMB = data and safety monitoring board; N/A = not applicable | ||